Cite
HARVARD Citation
Bardin, T. et al. (n.d.). FRI0333 Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination with Allopurinol: Results from a Phase III Study in Gout Patients Having an Inadequate Response to Standard of Care (Clear 2). Annals of the rheumatic diseases. p. 545. [Online].